DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Information source: Wyeth
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Leukemia, Myelocytic, Acute; Infusions, Intravenous/Ae (Adverse Effects)

Intervention: Mylotarg (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth

Summary

The purpose of this study is to evaluate the effect of corticosteroids on the frequency and severity of Mylotarg® infusion–related adverse events, to evaluate the effect of corticosteroids on the efficacy of Mylotarg® induced complete response (CR) and complete response with incomplete platelet recovery (CRp) at one-month post treatment.

Clinical Details

Official title: A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML)

Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study

Primary outcome: The effect of corticosteroids on the frequency and severity of Mylotarg® infusion-related adverse events.

Secondary outcome: The effect of corticosteroids on the efficacy of Mylotarg® induced complete response (CR) and complete response with incomplete platelets recovery (CRp) at one-month post treatment.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with CD33 positive, resistant or relapsed AML.

- Patients > 18 years of age.

- ECOG performance status 0-2.

Exclusion Criteria:

- Fever (>38), chills or hypotension (systolic BP<105mmHg) in the 48 hours preceding

therapy.

- Use of corticosteroids, diphenhydramine or acetaminophen within 24 hours of

enrollment.

- Participation in any other Mylotarg® protocol.

Locations and Contacts

Additional Information

Starting date: April 2002
Ending date: January 2004
Last updated: May 17, 2006

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012